Hagerman PJ - Search Results

1

Incomplete financial disclosure in a commentary on testing for fragile X gene mutations throughout the life span.

Hagerman PJ. Hagerman PJ. JAMA. 2009 Feb 11;301(6):601-2. doi: 10.1001/jama.2009.79. JAMA. 2009. PMID: 19211466 No abstract available.

2

Testing for fragile X gene mutations throughout the life span.

Hagerman RJ, Hagerman PJ. Hagerman RJ, et al. Among authors: hagerman pj. JAMA. 2008 Nov 26;300(20):2419-21. doi: 10.1001/jama.2008.684. JAMA. 2008. PMID: 19033593 Free PMC article. No abstract available.

3

Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.

Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, Herman K, Grigsby J, Greco CM, Berry-Kravis E, Tassone F, Hagerman PJ. Jacquemont S, et al. Among authors: hagerman pj, hagerman rj. JAMA. 2004 Jan 28;291(4):460-9. doi: 10.1001/jama.291.4.460. JAMA. 2004. PMID: 14747503

4

X inactivation and cellular mosaicism.

Hagerman RJ, Hagerman PJ. Hagerman RJ, et al. Among authors: hagerman pj. JAMA. 2006 Aug 23;296(8):930-1; author reply 931. doi: 10.1001/jama.296.8.930-c. JAMA. 2006. PMID: 16926349 No abstract available.

5

Fragile X syndrome.

Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB Jr, Moine H, Kooy RF, Tassone F, Gantois I, Sonenberg N, Mandel JL, Hagerman PJ. Hagerman RJ, et al. Among authors: hagerman pj. Nat Rev Dis Primers. 2017 Sep 29;3:17065. doi: 10.1038/nrdp.2017.65. Nat Rev Dis Primers. 2017. PMID: 28960184 Review.

6

Fragile X syndrome: a model of gene-brain-behavior relationships.

Hagerman RJ, Hagerman PJ. Hagerman RJ, et al. Among authors: hagerman pj. Mol Genet Metab. 2001 Sep-Oct;74(1-2):89-97. doi: 10.1006/mgme.2001.3225. Mol Genet Metab. 2001. PMID: 11592806 Review. No abstract available.

7

Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines.

Berry-Kravis E, Abrams L, Coffey SM, Hall DA, Greco C, Gane LW, Grigsby J, Bourgeois JA, Finucane B, Jacquemont S, Brunberg JA, Zhang L, Lin J, Tassone F, Hagerman PJ, Hagerman RJ, Leehey MA. Berry-Kravis E, et al. Among authors: hagerman pj, hagerman rj. Mov Disord. 2007 Oct 31;22(14):2018-30, quiz 2140. doi: 10.1002/mds.21493. Mov Disord. 2007. PMID: 17618523 Review.

8

Fragile X syndrome.

Hagerman PJ, Hagerman R. Hagerman PJ, et al. Curr Biol. 2021 Mar 22;31(6):R273-R275. doi: 10.1016/j.cub.2021.01.043. Curr Biol. 2021. PMID: 33756134 Free article.

9

Oral folic acid versus placebo in the treatment of males with the fragile X syndrome.

Hagerman RJ, Jackson AW, Levitas A, Braden M, McBogg P, Kemper M, McGavran L, Berry R, Matus I, Hagerman PJ. Hagerman RJ, et al. Among authors: hagerman pj. Am J Med Genet. 1986 Jan-Feb;23(1-2):241-62. doi: 10.1002/ajmg.1320230119. Am J Med Genet. 1986. PMID: 3513567 Review.

10

The fragile X syndrome: history, diagnosis, and treatment.

Hagerman RJ, McBogg P, Hagerman PJ. Hagerman RJ, et al. Among authors: hagerman pj. J Dev Behav Pediatr. 1983 Jun;4(2):122-30. doi: 10.1097/00004703-198306000-00009. J Dev Behav Pediatr. 1983. PMID: 6348096 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

255 results

Search Page